Targacept Sets New 1-Year Low at $2.68 (TRGT)
Targacept (NASDAQ:TRGT)’s share price reached a new 52-week low on Thursday , Stock Ratings Network reports. The stock traded as low as $2.68 and last traded at $2.75, with a volume of 272,478 shares changing hands. The stock had previously closed at $2.74.
A number of analysts have recently weighed in on TRGT shares. Analysts at MKM Partners cut their price target on shares of Targacept from $3.50 to $3.00 in a research note on Tuesday, July 29th. They now have a “neutral” rating on the stock.
The stock’s 50-day moving average is $3.71 and its 200-day moving average is $4.23. The company’s market cap is $93.6 million.
Targacept (NASDAQ:TRGT) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.24) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.33) by $0.09. The company had revenue of $0.04 million for the quarter. During the same quarter in the prior year, the company posted ($0.37) earnings per share. Analysts expect that Targacept will post $-1.09 EPS for the current fiscal year.
Targacept, Inc is a biopharmaceutical company. The Company is engaged in the design, discovery and development of NNR Therapeutics for the treatment of diseases and disorders of the nervous system.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.